Patents by Inventor Zhaohui Peng

Zhaohui Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240110255
    Abstract: The present invention discloses a extra thick hot rolled H section steel and a production method therefor. The extra thick hot rolled H section steel contains, by mass, the following chemical components: 0.04-0.11% of C, 0.10-0.40% of Si, 0.40-1.00% of Mn, 0.40-1.00% of Cr, 0.10-0.40% of Cu, 0.020-0.060% of Nb, 0.040-0.100% of V, 0.010-0.025% of Ti, 0.010-0.030% of Al, 0.0060-0.0120% of N, not more than 0.015% of P, not more than 0.005% of S, not more than 0.0060% of O, and the balance Fe and trace residual elements, wherein 0.090%?Nb+V+Ti?0.170%, 6.5?(V+Ti)/N?10.5, and 0.30%?CEV?0.48%. The extra thick hot rolled H section steel has a flange thickness of 90 mm-150 mm, has excellent comprehensive mechanical properties, and can well meet the needs for heavy supporting structural parts of high-rise buildings, large squares, bridge structures, etc.
    Type: Application
    Filed: October 27, 2021
    Publication date: April 4, 2024
    Inventors: Meng XIA, Baoqiao WU, Meizhuang WU, Jun XING, Jie WANG, Hui CHEN, Jingcheng YAN, Qi HUANG, Lin PENG, Junwei HE, Zhaohui DING, Qiancheng SHEN
  • Publication number: 20090215164
    Abstract: The invention relates to the application of a recombinant of adenovirus vector and human tumor suppressor p53 gene expression cassette for producing the medicine for treating proliferative disease. In particular the invention relates to the application of a recombinant of adenovirus vector and human tumor suppressor p53 gene expression cassette for producing the medicine for treating scar.
    Type: Application
    Filed: May 9, 2004
    Publication date: August 27, 2009
    Inventors: Zhaohui Peng, Xiaozhi Zhang
  • Publication number: 20050281785
    Abstract: The present invention discloses that recombinant p53 adenovirus can ameliorate the side effects normally associated with chemotherapy and radiotherapy. Administration of recombinant p53 adenovirus is effective in reducing the side effects of cancer therapy on patients, and improving the biochemical parameters of these patients. The invention also discloses that recombinant p53 adenovirus alone can improve the quality of life for cancer patients without being combined with other forms of cancer therapy such as chemotherapy or radiotherapy.
    Type: Application
    Filed: March 7, 2005
    Publication date: December 22, 2005
    Inventors: Zhaohui Peng, Xiaozhi Zhang